EnWave Signs Royalty-Bearing Commercial License with Established South American Food Manufacturer
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced […]
Seasoned business veteran Jarrett Boon steps up to the role of CEO as Brian John departs to Focus on Legacy Jupiter Wellness products.
Boon was one of the original thought leaders and investors in LifeLock, which was subsequently acquired for $2.3 billion. He […]
Wearable Devices Teams up with Qualcomm to Elevate Extended Reality Experience
This Collaboration Aims to Transform XR Industry Using the Mudra’s Touchless Control Technology YOKNEAM ILLIT, ISRAEL, Feb. 28, 2024 (GLOBE […]
EXL collaborates with AWS to accelerate commercialization of generative AI solutions
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions […]
Foremost Lithium Announces $10 Million Application for the Government of Canada’s Critical Mineral Infrastructure Fund
The Critical Mineral Infrastructure Fund (CMIF) is a $1.5B Government of Canada fund to support the development and expansion of […]
Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on […]
Nano Dimension Announces Important Business Updates:
The Company Plan for the Buy Back of Up to $200 Million of Shares Recently Commenced at Compelling Valuation Levels, […]
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical […]
Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
HeartCore Announces the Establishment of HeartCore Luvina Vietnam Co., Ltd.
NEW YORK and TOKYO, Feb. 28, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a […]
